| Interleukin-18 binding protein deficiency results in gut microbiota dysbiosis and aggravated diet-induced MASH in mice | JHEP reports | | | 2026 | 41 | 52 |
|
| Diabétologie : ce qui a changé en 2025 | Revue médicale suisse | | | 2026 | 19 | 0 |
|
| Autoimmunity in MASLD : Focus on autoantibodies, anti‐apolipoprotein A1 IgG and G protein‐coupled receptors | European journal of clinical investigation | | | 2025 | 85 | 406 |
|
| Prise en charge de la dyslipidémie diabétique | Revue médicale suisse | | | 2025 | 13 | 0 |
|
| Autoantibodies against apolipoprotein A-1 and cadmium : possible links tocardiovascular and liver diseases across multiple models | ESC (European Society of Cardiology) Congress 2025 | | | 2025 | 17 | 0 |
|
| Autoantibodies against apolipoprotein A-1 and cadmium : Possible links tocardiovascular and liver diseases across multiple models | 93rd EAS (European Atherosclerosis Society) Congress | | | 2025 | 21 | 0 |
|
| Modulation of STAT6 signaling for hepatoprotection | Frontiers in pharmacology | | | 2025 | 12 | 116 |
|
| Interleukin-18 binding protein protects against metabolic steatohepatitis | Hepatology communications | | | 2025 | 1 | 0 |
|
| Analogues du GLP-1 dans le traitement du diabète de type 2 et de l’obésité : la panacée ? | Revue médicale suisse | | | 2025 | 16 | 0 |
|
| Multi-omics correlates of insulin resistance and circadian parameters mapped directly from human serum | European journal of neuroscience | | | 2024 | 91 | 266 |
|
| Alterations of lipid homeostasis in morbid obese patients are partly reversed by bariatric surgery | iScience | | | 2024 | 96 | 102 |
|
| S100A9 exerts insulin-independent antidiabetic and anti-inflammatory effects | Science advances | | | 2024 | 352 | 199 |
|
| Linking antibody against apolipoprotein A-1 to nonalcoholic steatohepatitis in mice | 92nd EAS (European Atherosclerosis Society) Congress | | | 2024 | 12 | 0 |
|
| Corticosteroid therapy in older adults with cancer : Expert recommendations from a task force of the International Society of Geriatric Oncology | Journal of geriatric oncology | | | 2024 | 41 | 0 |
|
| Linking antibody against apolipoprotein A-1 to metabolic dysfunction-associatedsteatohepatitis in mice | ESC (Europan Society of Cardiology) Congress 2024 | | | 2024 | 10 | 0 |
|
| Geospatial clustering of auto-antibodies against apolipoprotein A-1, heavy metals,cardiovascular and liver diseases in the general population | ESC (Europan Society of Cardiology) Congress 2024 | | | 2024 | 14 | 0 |
|
| Diabétologie : ce qui a changé en 2023 | Revue médicale suisse | | | 2024 | 122 | 9 |
|
| Lysophosphatidylinositols Are Upregulated After Human β-Cell Loss and Potentiate Insulin Release | Diabetes | | | 2024 | 374 | 3 |
|
| N ADPH oxidases in healthy white adipose tissue and in obesity : function, regulation, and clinical implications | Obesity | | | 2024 | 115 | 116 |
|
| Linking Antibodies Against Apolipoprotein A-1 to Metabolic Dysfunction-Associated Steatohepatitis in Mice | International journal of molecular sciences | | | 2024 | 131 | 180 |
|
| Gastroparésie diabétique et diabète de type 1 | Revue médicale suisse | | | 2024 | 143 | 6 |
|
| Langerhans Cell Histiocytosis of the Suprasellar Region : Diagnosis on Thyroid Cytology | European thyroid journal | | | 2024 | 125 | 238 |
|
| Geospatial clustering of auto-antibodies against apolipoprotein A-1, heavy metals, cardiovascular and liver diseases in the general population | 92nd EAS (European Atherosclerosis Society) Congress | | | 2024 | 16 | 0 |
|
| Gynécologie-obstétrique. Prise en charge et dépistage du diabète gestationnel : ce qui a changé en 2023 | Revue médicale suisse | | | 2024 | 233 | 4 |
|
| Toutes nos différences… | Revue médicale suisse | | | 2024 | 91 | 7 |
|
| Interprofessional diabetes and foot management in low-and middle-income countries or humanitarian crises contexts | International Diabetes Federation (IDF) virtual congress | | | 2023 | 63 | 105 |
|
| Pied diabétique : une prise en charge complexe et multidisciplinaire | Revue médicale suisse | | | 2023 | 134 | 52 |
|
| Nonalcoholic fatty liver disease in type 1 diabetes : where are we? | Polskie Archiwum Medycyny Wewnętrznej | | | 2023 | 97 | 109 |
|
| GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes | Diabetes & metabolism | | | 2023 | 140 | 614 |
|
| A global research priority agenda to advance public health responses to fatty liver disease | Journal of hepatology | | | 2023 | 124 | 671 |
|
| Diabétologie : ce qui a changé en 2022 | Revue médicale suisse | | | 2023 | 152 | 32 |
|
| Role of Oxidative Stress and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Nonalcoholic Fatty Liver Disease | International journal of molecular sciences | | | 2023 | 136 | 216 |
|
| Circadian organization of lipid landscape is perturbed in type 2 diabetic patients | Cell reports medicine | | | 2023 | 278 | 162 |
|
| Stéatopathie non alcoolique (NAFLD) et diabète : le mauvais mariage | Revue médicale suisse | | | 2023 | 135 | 74 |
|
| Unnecessary thyroid surgery rate for suspicious nodule in the absence of molecular testing | European thyroid journal | | | 2023 | 218 | 738 |
|
| Traitement du diabète de type 2 : et si nous revenions à l’essentiel ? | Revue médicale suisse | | | 2023 | 98 | 64 |
|
| A multi–society Delphi consensus statement on new fatty liver disease nomenclature | Journal of hepatology | | | 2023 | 151 | 1,609 |
|
| The impact of transsphenoidal surgery on pituitary function in patients with non-functioning macroadenomas | Endocrine | | | 2023 | 149 | 417 |
|
| Neuropathie diabétique : mise au point | Revue médicale suisse | | | 2022 | 176 | 1,220 |
|
| Effectiveness of Therapeutic Patient Education Interventions in Obesity and Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials | Nutrients | | | 2022 | 193 | 332 |
|
| NAFLD: From Mechanisms to Therapeutic Approaches | Biomedicines | | | 2022 | 156 | 231 |
|
| Allergie à l’insuline : comment faire ? | Revue médicale suisse | | | 2022 | 148 | 644 |
|
| Non-alcoholic fatty liver disease in type 1 diabetes: prevalence and pathophysiology | Frontiers in endocrinology | | | 2022 | 159 | 392 |
|
| Diabète pancréatoprive | Revue médicale suisse | | | 2022 | 542 | 412 |
|
| Pheochromocytoma presented by Takotsubo, unmasked by accumulation of paroxetine, in a cytochrome poor metabolizer patient: A case report | Thérapie | | | 2022 | 372 | 1 |
|
| Interleukin-18 in metabolism: from mice physiology to human diseases | Frontiers in endocrinology | | | 2022 | 186 | 522 |
|
| Canakinumab in patients with COVID-19 and type 2 diabetes – a multicentre, randomised, double-blind, placebo-controlled trial | EClinicalMedicine | | | 2022 | 137 | 154 |
|
| Sex-specific modulation of circulating growth differentiation factor-15 in patients with type 2 diabetes and/or obesity | Endocrine connections | | | 2022 | 239 | 223 |
|
| (650) Efficacy of therapeutic patient education interventions in metabolic disorders: a systematic review and meta-analysis | 58th EASD Annual Meeting of the European Association for the Study of Diabetes | | | 2022 | 252 | 7 |
|
| Circulating 1,5-anhydroglucitol as a biomarker of ß-cell mass independent of a diabetes phenotype in human subjects | The Journal of clinical endocrinology and metabolism | | | 2022 | 424 | 2 |
|
| Moderate to Severe Soft Tissue Diabetic Foot Infections: A Randomized, Controlled, Pilot Trial of Post-debridement Antibiotic Treatment for 10 versus 20 days | Annals of surgery | | | 2022 | 265 | 455 |
|
| NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook | Antioxidants | | | 2022 | 287 | 1,429 |
|
| Dernières recommandations européennes sur les dyslipidémies | Revue médicale suisse | | | 2022 | 398 | 1,705 |
|
| Hepatic non-parenchymal S100A9-TLR4-mTORC1 axis normalizes diabetic ketogenesis | Nature communications | | | 2022 | 387 | 133 |
|
| Diabète : la pandémie comme révélateur de nos succès/nos failles | Revue médicale suisse | | | 2022 | 57 | 51 |
|
| Diabétologie | Revue médicale suisse | | | 2022 | 96 | 75 |
|
| Hépatopathie et diabète de type 2 | Leading Opinions. Médecine Interne | | | 2022 | 125 | 0 |
|
| Tratamiento podológico del pie diabético | Encyclopédie médico-chirurgicale. Podología | | | 2022 | 130 | 0 |
|
| Systematic Review and Meta-Analysis of the Usefulness of Epicardial Fat Thickness as a Non-Invasive Marker of the Presence and Severity of Nonalcoholic Fatty Liver Disease | Biomedicines | | | 2022 | 160 | 159 |
|
| Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes | Cardiovascular diabetology | | | 2022 | 116 | 323 |
|
| Prise en charge podologique du pied diabétique | Encyclopédie médico-chirurgicale. Podologie | | | 2022 | 148 | 0 |
|
| Growth differentiation factor-15 prevents glucotoxicity and connexin-36 downregulation in pancreatic beta-cells | Molecular and cellular endocrinology | | | 2022 | 110 | 303 |
|
| Le diabète : une pandémie oubliée ? | Revue médicale suisse | | | 2021 | 130 | 312 |
|
| Inhibiteurs du SGLT2 : que des bénéfices? | Revue médicale suisse | | | 2021 | 386 | 455 |
|
| Is routine measurement of the serum C-reactive protein level helpful during antibiotic therapy for diabetic foot infection? | Diabetes, Obesity and Metabolism | | | 2021 | 195 | 0 |
|
| Diabète de type MODY : une entité souvent méconnue | Revue médicale suisse | | | 2021 | 189 | 368 |
|
| Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patients | Acta Physiologica | | | 2021 | 403 | 3 |
|
| Diabétologie | Revue médicale suisse | | | 2021 | 208 | 2 |
|
| Pathophysiology of NASH in endocrine diseases | Endocrine Connections | | | 2021 | 239 | 339 |
|
| Hypothyroidism-Associated Dyslipidemia: Potential Molecular Mechanisms Leading to NAFLD | International journal of molecular sciences | | | 2021 | 162 | 391 |
|
| Diabétologie | Revue médicale suisse | | | 2020 | 247 | 2 |
|
| Diabète: et si on se mettait à la place du patient? | Revue médicale suisse | | | 2020 | 252 | 0 |
|
| Effectiveness and safety of insulin glargine 300 U/mL in insulin-naïve patients with type 2 diabetes after failure of oral therapy in a real-world setting | Diabetes, Obesity and Metabolism | | | 2020 | 494 | 375 |
|
| Thirteen-year trends in the prevalence of diabetes according to socioeconomic condition and cardiovascular risk factors in a swiss population | BMJ Open Diabetes Res Care | | | 2020 | 344 | 229 |
|
| Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland | Diabetes, Metabolic Syndrome and Obesity | | | 2020 | 306 | 233 |
|
| La NASH: une complication moins connue mais importante du diabète | Revue médicale suisse | | | 2020 | 363 | 0 |
|
| The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet | Translational Research | | | 2020 | 571 | 382 |
|
| Quelle place pour les inhibiteurs de la DPP-4 en 2020? | Revue médicale suisse | | | 2020 | 557 | 0 |
|
| Ulcère du pied chez un patient avec un diabète : quelle prise en charge médico-chirurgicale ? | Revue médicale suisse | | | 2020 | 350 | 1 |
|
| Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report | BMC Endocrine Disorders | | | 2020 | 214 | 166 |
|
| Diabète après transplantation rénale : mise au point | Revue médicale suisse | | | 2020 | 362 | 4 |
|
| Three versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: A prospective, randomized, non-inferiority pilot trial | Clinical Infectious Diseases | | | 2020 | 349 | 1,240 |
|
| Insuffisance rénale chronique et nouveaux traitements antidiabétiques : tour d'horizon en 2019 | Revue médicale suisse | | | 2019 | 681 | 304 |
|
| Thirteen-year trends in the prevalence of diabetes in an urban region of Switzerland: a population-based study | Diabetic Medicine | | | 2019 | 267 | 0 |
|
| Salivary cortisol is not associated with incident insulin resistance or type 2 diabetes mellitus | Endocrine Connections | | | 2019 | 325 | 139 |
|
| Faut-il prescrire plus d'inhibiteurs SGLT-2 ? | Revue médicale suisse | | | 2019 | 311 | 176 |
|
| [News in diabetology 2018] | Revue médicale suisse | | | 2019 | 280 | 99 |
|
| Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism | Scientific Reports | | | 2019 | 478 | 141 |
|
| Nonalcoholic fatty liver disease burden | Swiss Medical Weekly | | | 2019 | 318 | 267 |
|
| Prise en charge de la dyslipidémie chez les patients avec un diabète de type 1 | Revue médicale suisse | | | 2018 | 526 | 112 |
|
| Diabétologie | Revue médicale suisse | | | 2018 | 421 | 83 |
|
| Observance thérapeutique et empilage médicamenteux | Revue médicale suisse | | | 2018 | 374 | 219 |
|
| Fibroblast Growth Factor 15/19 - From Basic Functions to Therapeutic Perspectives | Endocrine Reviews | | | 2018 | 505 | 334 |
|
| Transition optimale hôpital-domicile d'un patient diabétique de type 2 : quelques outils | Revue médicale suisse | | | 2018 | 573 | 215 |
|
| Consequences of the Adoption of the IADPSG versus Carpenter and Coustan Criteria to Diagnose Gestational Diabetes: A Before-After Comparison | Experimental and Clinical Endocrinology and Diabetes | | | 2018 | 519 | 2 |
|
| An Overview on Diabetic Foot Infections, including Issues Related to Associated Pain, Hyperglycemia and Limb Ischemia | Current Pharmaceutical Design | | | 2018 | 495 | 1 |
|
| Diabète prégestationnel : une entité de plus en plus fréquente | Revue médicale suisse | | | 2018 | 515 | 274 |
|
| Diabète de type 1, activité physique et nouvelles technologies | Revue médicale suisse | | | 2018 | 790 | 509 |
|
| β-Klotho deficiency protects against obesity through a crosstalk between liver, microbiota, and brown adipose tissue | JCI insight | | | 2017 | 591 | 298 |
|
| Utilité de la mesure en continu de la glycémie chez les patients diabétiques de type 2 | Revue médicale suisse | | | 2017 | 397 | 0 |
|
| Treatment challenges in type 1 diabetes after roux-en-Y gastric bypass | Swiss Medical Weekly | | | 2017 | 415 | 238 |
|
| AMPK activation caused by reduced liver lactate metabolism protects against hepatic steatosis in MCT1 haploinsufficient mice | Molecular Metabolism | | | 2017 | 421 | 0 |
|
| Diabète sucré secondaire à une endocrinopathie : quand y penser ? | Revue médicale suisse | | | 2017 | 555 | 1,178 |
|
| Diètes cétogènes : la solution miracle ? | Revue médicale suisse | | | 2017 | 1,349 | 868 |
|
| Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies | Nutrients | | | 2017 | 475 | 0 |
|
| Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease | Nutrients | | | 2017 | 494 | 0 |
|
| Traitement du diabète: quand faire appel au diabétologue? | Revue médicale suisse | | | 2017 | 378 | 251 |
|
| Grip strength is not associated with incident type 2 diabetes mellitus in healthy adults: The CoLaus study | Diabetes Research and Clinical Practice | | | 2017 | 478 | 0 |
|
| Diabétologie | Revue médicale suisse | | | 2017 | 414 | 138 |
|
| GPR40 mediates potential positive effects of a saturated fatty acid enriched diet on bone | Molecular Nutrition and Food Research | | | 2017 | 569 | 462 |
|
| Effects of Antidiabetic Drugs on Gut Microbiota Composition | Genes | | | 2017 | 446 | 0 |
|
| Use of Dipeptidyl-Peptidase IV Inhibitors and Bullous Pemphigoid | Dermatology | | | 2017 | 431 | 0 |
|
| Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples | Journal of Immunological Methods | | | 2017 | 404 | 1 |
|
| Place des nouveaux antidiabétiques dans la population gériatrique | Revue médicale suisse | | | 2016 | 426 | 1 |
|
| Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance | FASEB Journal | | | 2016 | 374 | 0 |
|
| Fasting glycaemia to simplify screening for gestational diabetes | BJOG: an International Journal of Obstetrics and Gynaecology | | | 2016 | 598 | 1 |
|
| Diabète gestationnel – quelles sont les approches non médicales ? | Revue médicale suisse | | | 2016 | 431 | 1 |
|
| Comment faire pour prévenir le diabète de type 2 en Suisse? | Revue médicale suisse | | | 2016 | 426 | 2 |
|
| Leptin as a Potential Regulator of FGF21 | Cellular physiology and biochemistry | | | 2016 | 633 | 275 |
|
| Preserving of Postnatal Leptin Signaling in Obesity-Resistant Lou/C Rats following a Perinatal High-Fat Diet | PloS one | | | 2016 | 523 | 215 |
|
| Sécurité cardiovasculaire des antidiabétiques | Revue médicale suisse | | | 2016 | 433 | 0 |
|
| Diabétologie | Revue médicale suisse | | | 2016 | 379 | 0 |
|
| Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection | Arteriosclerosis, Thrombosis, and Vascular Biology | | | 2016 | 631 | 1 |
|
| Low birth weight leads to obesity, diabetes and increased leptin levels in adults: the CoLaus study | Cardiovascular Diabetology | | | 2016 | 541 | 304 |
|
| Endocrine causes of nonalcoholic fatty liver disease | World Journal of Gastroenterology | | | 2015 | 491 | 0 |
|
| Free Fatty Acids Impair FGF21 Action in HepG2 Cells | Cellular physiology and biochemistry | | | 2015 | 565 | 925 |
|
| Metformine : nouvelles données pour une ancienne molécule | Revue médicale suisse | | | 2015 | 455 | 2 |
|
| Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21 | Journal of Endocrinology | | | 2015 | 828 | 481 |
|
| Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? | Molecular and Cellular Endocrinology | | | 2015 | 545 | 2,028 |
|
| Classification du diabète : vers une hétérogénéité croissante | Revue médicale suisse | | | 2015 | 402 | 0 |
|
| Ketogenic Diet Impairs FGF21 Signaling and Promotes Differential Inflammatory Responses in the Liver and White Adipose Tissue | PloS one | | | 2015 | 630 | 556 |
|
| Le diabète en 2015 : en augmentation constante, mais avec une offre thérapeutique qui s'élargit | Revue médicale suisse | | | 2015 | 410 | 1 |
|
| Prise en charge des facteurs de risque des maladies cardiovasculaires : qu'est-ce qui a vraiment changé en 15 ans ? | Revue médicale suisse | | | 2015 | 433 | 1 |
|
| Edulcorants artificiels et diabète : faux amis ? | Revue médicale suisse | | | 2015 | 406 | 0 |
|
| ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content | Journal of Lipid Research | | | 2015 | 474 | 0 |
|
| Serum Vitamin D Concentrations Are Not Associated with Insulin Resistance in Swiss Adults | The Journal of nutrition | | | 2015 | 547 | 0 |
|
| Transition en diabétologie | Revue médicale suisse | | | 2015 | 566 | 1 |
|
| Diets and nonalcoholic fatty liver disease: The good and the bad | Clinical nutrition | | | 2014 | 683 | 1 |
|
| Capsule Commentary on Patrick et al., Trends in Insulin Initiation and Treatment Intensification among Patients with Type 2 Diabetes | Journal of general internal medicine | | | 2014 | 610 | 1 |
|
| Maladies hépatiques chroniques et diabète | Revue médicale suisse | | | 2014 | 495 | 0 |
|
| Traitement combiné d'insuline et d'analogue du GLP-1 : qu'en attendre ? | Revue médicale suisse | | | 2014 | 580 | 0 |
|
| Ostα-/- mice exhibit altered expression of intestinal lipid absorption genes, resistance to age-related weight gain, and modestly improved insulin sensitivity | American Journal of Physiology. Gastrointestinal and Liver Physiology | | | 2014 | 463 | 0 |
|
| Muscle-specific activation of Ca(2+)/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice | Diabetologia | | | 2014 | 511 | 0 |
|
| Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice | Endocrinology | | | 2013 | 776 | 0 |
|
| CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance | Proceedings of the National Academy of Sciences | | | 2013 | 511 | 0 |
|
| Increased FGF21 plasma levels in humans with sepsis and SIRS | Endocrine connections | | | 2013 | 649 | 344 |
|
| Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside | Diabetes & metabolism | | | 2013 | 653 | 0 |
|
| Enhanced fasting glucose turnover in mice with disrupted action of TUG protein in skeletal muscle | Journal of Biological Chemistry | | | 2013 | 512 | 0 |
|
| Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance | Endocrinology | | | 2013 | 471 | 0 |
|
| Sport et diabète de type 1 | Revue médicale suisse | | | 2013 | 686 | 0 |
|
| Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance | Journal of Endocrinology | | | 2013 | 695 | 0 |
|
| Thyroid hormone receptor-α gene knockout mice are protected from diet-induced hepatic insulin resistance | Endocrinology | | | 2012 | 467 | 0 |
|
| Development of insulin resistance in mice lacking PGC-1α in adipose tissues | Proceedings of the National Academy of Sciences | | | 2012 | 424 | 0 |
|
| Dissociation of inositol-requiring enzyme (IRE1α)-mediated c-Jun N-terminal kinase activation from hepatic insulin resistance in conditional X-box-binding protein-1 (XBP1) knock-out mice | Journal of Biological Chemistry | | | 2012 | 443 | 0 |
|
| Sommeil et diabète | Revue médicale suisse | | | 2012 | 517 | 0 |
|
| Diabète et stéatose hépatique non alcoolique | Revue médicale suisse | | | 2012 | 638 | 0 |
|
| Weight and mortality in adults with diabetes | JAMA | | | 2012 | 601 | 0 |
|
| Insulin resistance is associated with elevated serum pigment epithelium-derived factor (PEDF) levels in morbidly obese patients | Acta Diabetologica | | | 2012 | 446 | 0 |
|
| Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice | Cell Metabolism | | | 2011 | 463 | 0 |
|
| Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance | Hepatology | | | 2011 | 451 | 1 |
|
| Pregnancy does not accelerate corticotroph tumor progression in Nelson's syndrome | Journal of Clinical Endocrinology and Metabolism | | | 2011 | 485 | 0 |
|
| SGLT2 deletion improves glucose homeostasis and preserves pancreatic beta-cell function | Diabetes | | | 2011 | 403 | 0 |
|
| Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2 | Proceedings of the National Academy of Sciences | | | 2011 | 514 | 0 |
|
| Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance | Cell Metabolism | | | 2010 | 474 | 0 |
|
| A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain | American Journal of Physiology. Endocrinology and Metabolism | | | 2010 | 450 | 0 |
|
| Effects of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals | Diabetologia | | | 2010 | 648 | 0 |
|
| Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients | NMCD. Nutrition Metabolism and Cardiovascular Diseases | | | 2009 | 649 | 0 |
|
| Mucocutaneous papillomatous papules in Cowden's syndrome | Clinical and experimental dermatology | | | 2008 | 562 | 0 |
|
| Assessment of hepatic glucose metabolism by indirect calorimetry in combination with a non-invasive technique using naturally enriched 13C glucose in healthy children and adolescents | Hormone Research | | | 2004 | 434 | 0 |
|
| Metabolism of oral glucose in children born small for gestational age: evidence for an impaired whole body glucose oxidation | Metabolism | | | 2004 | 442 | 0 |
|
| Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1 | The Journal of clinical endocrinology and metabolism | | | 2003 | 642 | 0 |
|
